Exact Sciences Profile

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:3em;padding-top: 35px;;'>EXA</div>

Performance

2 / 100

Odds of Distress

6
Analyze Filter   Earning Report: February 20, 2020
Equity ratings for Exact Sciences Corporation are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 25, 2019 and ending today January 23, 2020. Click here to learn more.

Exact Sciences Profile

Upcoming quarterly earning report is expected on February 20, 2020. Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 1977 people. more on Exact Sciences
Exact Sciences Fama & French Business Services
Business Services
Fama & French Classification
Exact Sciences SEC Filings
Exact Sciences SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameExact Sciences Corporation
ChairmanKevin ConroyView All
Thematic Classification
Currently Active Investing Idea
  Business Services
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Exact Sciences
Piotroski F Score
Academic score to determine the current strength of Exact Sciences financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
Exact Sciences ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of Exact Sciences representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
EBITDA Margin
Gross Margin
Profit Margin
Exact Sciences Corporation (EXAS) is traded on BATS Exchange in USA. It is located in 441 Charmany Drive, Madison, WI 53719, United States and employs 1,977 people. Exact Sciences is listed under Business Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with current market capitalization of 13.5 B. Exact Sciences conducts business under Healthcare sector and is part of Diagnostics & Research industry. The entity has 129.83 M outstanding shares of which 14.38 M shares are currently shorted by private and institutional investors with about 8.07 trading days to cover. EXACT SCIENCES CO currently holds about 1.16 B in cash with (186.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.94.
Check Exact Sciences Probability Of Bankruptcy

Ownership Allocation (%)

Exact Sciences Target Price Odds Analysis

Odds Below 92.18HorizonTargetOdds Above 92.18
72.06%30 days 92.18 27.80%
Based on normal probability distribution, the odds of Exact Sciences to move above current price in 30 days from now is about 27.8 (This Exact Sciences Corporation probability density function shows the probability of Exact Sciences Stock to fall within a particular range of prices over 30 days) .

Exact Sciences Top Holders

Exact Sciences Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Calamos Advisors LlcDebt40.8 M46.4 M
Kames Capital PlcCommon Shares381.8 K35.3 M
Artemis Investment Management LlpCommon Shares147.5 K13.3 M
View Exact Sciences Diagnostics

Exact Sciences Corporation Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Exact Sciences Against Markets

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module

Exact Sciences Upcoming and Recent Events

Exact Sciences Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 20, 2020
Next Earnings ReportMay 5, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 20, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Exact Sciences Corporate Filings

Exact Sciences SEC Reporting

Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
Other Events
Unclassified Corporate Event
Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Entry into a Material Definitive Agreement

Exact Sciences Corporate Directors

Katherine Napier Independent Director
Sally Crawford Independent Director
David Thompson Lead Independent Director
Continue to Investing Opportunities. Please also try Commodity Channel Index module to use commodity channel index to analyze current equity momentum.
Company logos by clearbit